Cite

HARVARD Citation

    Sakai, F. et al. (2021). Phase 2 randomized placebo‐controlled study of lasmiditan for the acute treatment of migraine in Japanese patients. Headache. 61 (5), pp. 755-765. [Online]. 
  
Back to record